“I am inspired by Anavasi’s mission to bring sensitive, specific, fast testing into environments where timely decisions can be made at a price that can be broadly accessible.”

Bryan Crane, Ph.D. is currently the Vice President, Head of System Design at Illumina, a global leader in the field of instrumentation for genomic analysis. Dr. Crane has served in R&D at Illumina for 15 years and has been deeply involved in innovations and productization of several generations of market-leading instrumentation and consumable platforms. Dr. Crane is responsible for collaborative optimization of product architecture, prioritizing R&D investment, evolving the development process, and partnerships with worldwide suppliers. He is also responsible for growing and developing a large engineering team, instilling the innovative, fast moving R&D culture of Illumina.

Dr. Crane earned his Ph.D. in Mechanical Engineering from the Massachusetts Institute of Technology, with a focus on BioInstrumentation. He holds a B.S. in Mechanical and Aerospace Engineering from the University of Missouri-Columbia.

“I am looking forward to assisting Anavasi as they seek to bring their ground breaking technology to the market.”

Arthur Kirsch is an active consultant and board member in the biomedical arena. Arthur had a 40+ year career (Drexel Burnham,Vector Securities,GCA Global) in Investment Banking working with a variety of companies from start-ups to large public entities. He had a strong focus within the healthcare arena advising companies from raising capital to eventual strategic transactions.

He has served on a number of public company boards typically as an audit committee member. He is currently a director of Liquidia Corp. (Nasdaq: LQDA) a Biopharmaceutical company focused on the development and commercialization of products in pulmonary hypertension. He received a B.A. from the University of Rhode Island and an M.B. A. From Baruch College.

”I’m privileged and honored to work with the Anavasi team as they change the nature of point-of-care diagnostic testing, and in reality, the nature of medicine.”

David L. Vied is the Global Sector Leader for the Medical Devices practice for Korn Ferry. For over 25 years, David has advised medical device clients on talent management and talent assessment issues, addressing such topics as CEO succession, innovation and transformation acceleration, and executive development. He has conducted search assignments in areas that range from medical affairs, research and development, and regulatory compliance through to CEO and board roles. His clients run the gamut of the industry from pre-revenue start-up to established and dominant multi-billion-dollar market cap environments.

He serves as a director of Cyanotech Corporation (Nasdaq: CYAN), a developer and marketer of microalgae based nutritional supplements. He received a BA degree in Communication Studies from California State University at Sacramento and a MS degree in Labor and Industrial Relations from the University of North Texas.